Hepatosplenic T cell lymphoma in inflammatory bowel disease.

Gut

GI Section, Imperial College London, Hammersmith Hospital, Du Cane Road, London W12 0NN, UK.

Published: December 2008

Download full-text PDF

Source
http://dx.doi.org/10.1136/gut.2008.163279DOI Listing

Publication Analysis

Top Keywords

hepatosplenic cell
4
cell lymphoma
4
lymphoma inflammatory
4
inflammatory bowel
4
bowel disease
4
hepatosplenic
1
lymphoma
1
inflammatory
1
bowel
1
disease
1

Similar Publications

Immunological and protective evaluation of purE/purK gene-deletion mutant of Brucella melitensis M5 strain.

Microb Pathog

January 2025

Changchun Veterinary Research Institute, Chinese Academy of Agricultural Sciences, Yujinxiang Street 573, Changchun, Jilin, 130122, China. Electronic address:

Brucellosis is listed by the World Health Organization as one of the seven most neglected global zoonotic diseases. A live-attenuated vaccine is still the main strategy used to prevent the spread of brucellosis. In this study, we constructed a two-gene (purE and purK)-deletion vaccine in Brucella melitensis vaccine strain M5 with homologous recombination.

View Article and Find Full Text PDF

Arsenic trioxide preconditioning attenuates hepatic ischemia- reperfusion injury in mice: Role of ERK/AKT and autophagy.

Chin Med J (Engl)

January 2025

Key Laboratory of Hepatosplenic Surgery, Ministry of Education, Department of Minimal Invasive Hepatic Surgery, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.

Background: Arsenic trioxide (ATO) is indicated as a broad-spectrum medicine for a variety of diseases, including cancer and cardiac disease. While the role of ATO in hepatic ischemia/reperfusion injury (HIRI) has not been reported. Thus, the purpose of this study was to identify the effects of ATO on HIRI.

View Article and Find Full Text PDF

Potential and development of cellular vesicle vaccines in cancer immunotherapy.

Discov Oncol

January 2025

Department of Breast Surgery, The First Affiliated Hospital of Harbin Medical University, No. 23, Youzheng Street, Nangang District, Harbin, 150001, China.

Cancer vaccines are promising as an effective means of stimulating the immune system to clear tumors as well as to establish immune surveillance. In this paper, we discuss the main platforms and current status of cancer vaccines and propose a new cancer vaccine platform, the cytosolic vesicle vaccine. This vaccine has a unique structure that can integrate antigen and adjuvant carriers to improve the delivery efficiency and immune activation ability, which brings new ideas for cancer vaccine design.

View Article and Find Full Text PDF

Background: The detrimental effects of a high-fat diet (HFD) extend beyond metabolic consequences and include systemic chronic inflammation (SCI), immune dysregulation, and gut health disruption.

Objectives: In this study, we used Mendelian randomization (MR) to investigate the relationship between HFD, gut microbiota, and SCI.

Methods: Genetic variants associated with dietary fat were utilized to explore causal relationships.

View Article and Find Full Text PDF

Study on clinical features of early death in older patients with acute promyelocytic leukemia.

Ann Hematol

December 2024

Key Laboratory of Hepatosplenic Surgery, Ministry of Education, The First Affiliated Hospital of Harbin Medical University, Harbin, 150001, People's Republic of China.

This study aimed to analyze the baseline clinical characteristics, as well as the clinical features and risk factors of early death (ED) in older patients with acute promyelocytic leukemia (APL). A retrospective analysis was conducted on 198 consecutive older patients (age ≥ 50 years) with newly diagnosed APL who received arsenic trioxide alone as induction therapy, with 354 younger patients (age < 50 years) as controls. Ten easily obtainable clinical parameters were selected.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!